Aspirin for the second hundred years: New uses for an old drug

Pharmacology and Toxicology

Volumn 81, Issue 4, 1997, Pages 151-152

  Vainio, Harri ^a   Morgan, Gareth ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CARDIOVASCULAR DISEASE; COLORECTAL CANCER; DRUG INDICATION; FEVER; HUMAN; INFLAMMATION; PAIN; PRIORITY JOURNAL; RHEUMATIC DISEASE; SHORT SURVEY;

SALIX;

EID: 0030762828     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb02060.x     Document Type: Short Survey

References (7)

1. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Brit. Med. J. 1994, 308, 81-106.
2. Breitner, J. C. S: The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 1996, 47, 401-411.
3. Dreser, H.: Pharmacologisches über Aspirin (acetylsalicyl-saüre) Pflügers Arch., 1899, 76, 306-318.
4. Morgan, G. P. & J. G. Williams: Inflammatory mediators in the oesophagus. Gut 1994, 35, 297-298.
5. Ridker, P. M., M. Cushman, M. J. Stampfer, R. P. Tracy & C. H. Hennekens: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New. Engl. J. Med. 1997, 336, 973-979.
6. Vane, J. R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, 1971, 231, 232-235.
7. Waddell, W. R. & R. W. Loughry: Sulindac for polyposis of the colon. J. Surg. Oncol. 1983, 24, 83-87.